“…DNP effectively reduced the weight of obese individuals but caused notable dysfunctions in the heart, liver, and other organs due to the accumulation of DNP in these organs. [45] According to our results, MN-TADNP treatment decreased DNP accumulation in the heart, liver, kidney, spleen, and lung to a minimal level, while there was relatively high organ accumulation of DNP for O-DNP-and O-TADNP-treated groups (Figure 3I-K; Figure S7, Supporting Information). Notably, the DNP content in heart tissue in the MN-TADNP-treated group was the lowest compared with oral DNP or TADNP treatment, suggesting that MN-TADNP treatment most effectively prevented the accumulation of DNP in the heart tissue, which is favorable for alleviating the cardiotoxicity of DNP.…”